Academic literature on the topic 'EGFR / ErbB-1 / HER1'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'EGFR / ErbB-1 / HER1.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "EGFR / ErbB-1 / HER1":
Elster, Naomi, Sinead Toomey, Yue Fan, Mattia Cremona, Clare Morgan, Karolina Weiner Gorzel, Una Bhreathnach, et al. "Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer." Therapeutic Advances in Medical Oncology 10 (January 1, 2018): 175883591877829. http://dx.doi.org/10.1177/1758835918778297.
Erben, Philipp, Felix Wezel, Ralph Wirtz, Thomas Martini, Doron Stein, Cleo-Aaron Weis, Arndt Hartmann, and Christian Bolenz. "Bedeutung der ERBB-Rezeptorfamilie beim Urothelkarzinom der Harnblase: mRNA-Expression und prognostische Relevanz." Aktuelle Urologie 48, no. 04 (July 27, 2017): 356–62. http://dx.doi.org/10.1055/s-0043-110403.
Hullmann, Grace, and Michael A. Azfer. "Immunogenic properties of outer membrane protein of Acinetobacter baumannii that loaded on chitosan nanoparticles." American Journal of BioMedicine 5, no. 1 (February 11, 2017): 32–44. http://dx.doi.org/10.18081/2333-5106/017-32-44.
Shen, Wang, Jeffrey Bacha, Dennis Brown, Sarath Kanekal, Neil Sankar, ZhenZhong Wang, Harry Pedersen, et al. "THER-01. PRECLINICAL DEVELOPMENT OF EO1001, A NOVEL IRREVERSIBLE BRAIN PENETRATING PAN-ErbB INHIBITOR." Neuro-Oncology Advances 1, Supplement_1 (August 2019): i10—i11. http://dx.doi.org/10.1093/noajnl/vdz014.044.
Ma, Fei, Qiao Li, Xiuwen Guan, Shanshan Chen, Zongbi Yi, Bo Lan, Puyuan Xing, et al. "Safety, efficacy, and biomarker analysis of pyrotinib in combination with capecitabine in HER2-positive metastatic breast cancer patients: A phase I clinical trial." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 1035. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1035.
Choudhury, Noura, Alexa Campanile, Tatjana Antic, James Lloyd Wade, Walter Michael Stadler, Yusuke Nakamura, and Peter H. O'Donnell. "Afatinib activity in platinum-refractory metastatic urothelial carcinoma (UC) patients with ErbB alterations: Results of a phase II trial." Journal of Clinical Oncology 34, no. 2_suppl (January 10, 2016): 459. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.459.
Choudhury, Noura, Alexa Campanile, James Lloyd Wade, Tatjana Antic, Walter Michael Stadler, Yusuke Nakamura, and Peter H. O'Donnell. "Association of HER2 and ErbB3 molecular alterations with afatinib sensitivity in platinum-refractory metastatic urothelial carcinoma (UC) in a phase II trial." Journal of Clinical Oncology 33, no. 7_suppl (March 1, 2015): 312. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.312.
Janjigian, Yelena Yuriy, David Ilson, David Paul Kelsen, Mark Schattner, Adriana Heguy, and Efsevia Vakiani. "A phase II study of afatinib (BIBW 2992) in patients with advanced HER2-positive trastuzumab-refractory esophagogastric cancer." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): TPS4144. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps4144.
Schuler, Martin H., David Planchard, James Chih-Hsin Yang, Joo-Hang Kim, Filippo De Marinis, Yuh-Min Chen, Caicun Zhou, et al. "Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator’s choice chemotherapy following progression on afatinib monotherapy." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 7557. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.7557.
Choudhury, Noura J., Alexa Campanile, Tatjana Antic, Kai Lee Yap, Carrie A. Fitzpatrick, James L. Wade, Theodore Karrison, Walter M. Stadler, Yusuke Nakamura, and Peter H. O’Donnell. "Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations." Journal of Clinical Oncology 34, no. 18 (June 20, 2016): 2165–71. http://dx.doi.org/10.1200/jco.2015.66.3047.
Dissertations / Theses on the topic "EGFR / ErbB-1 / HER1":
Blancafort, Jorquera Adriana. "Fatty acid synthase expression and inhibition in cancer." Doctoral thesis, Universitat de Girona, 2016. http://hdl.handle.net/10803/671774.
En aquesta tesi s’estudia la relació entre l’expressió de FASN (sintasa d'àcids grassos) i les característiques clinicopatològiques i antropomètriques en pacients amb càncer de mama, per esbrinar el paper de FASN com a pronòstic de càncer de mama d’estadis primerencs. També s'estudia l’expressió de FASN i la seva inhibició (sola o en combinació amb la inhibició de la ruta EGFR/HER/ErbB) en models cel·lulars i animals (xenografts i ortoxenopatients) de càncer de pulmó HER1+/FASN+, i en càncer de mama HER2+/FASN+. Finalment, s’han desenvolupat models pre-clínics de càncer de mama HER2+ resistents a teràpies anti-HER2 (trastuzumab i lapatinib) per estudiar l’expressió de FASN i altres proteïnes involucrades en la resistència i també, l’eficàcia anti-tumoral in vivo dels inhibidors de FASN, sols o en combinació. Com a conclusió, es descriu FASN com a possible nova diana anti-tumoral (sola o en combinació) per futurs estudis pre-clínics i clínics en models tumorals FASN+
Doctorat en Ciències Experimentals i Sostenibilitat
Bernardes, Vanessa de Fatima. "Receptores C-ERBB-1 (EGFR) e C-ERBB-2 (HER-2) em carcinoma de células escamosas de Boca." Universidade Federal de Minas Gerais, 2010. http://hdl.handle.net/1843/BUOS-8GXLJS.
Cirne, Lima Fernando Krebs. "Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2006. http://hdl.handle.net/10183/7802.